ARCHIVES

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

This article is from The Cancer Letter archive.

Vol. 08 No. 21 | May 21, 1982

Download PDF Visit The Full Archive

Related Articles

City of Hope CEO Michael Friedman: Cancer Centers Must Adapt; “Not Losing Sleep” Over Sequestration

April 5, 2013

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

In Brief: Adjuvant Chemotherapy Standard Practice For Breast Cancer At Milan, Bonadonna Says

May 7, 1976

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995